Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | 6-propyl-2-thiouracil | increases expression | ISO | Dydc2 (Rattus norvegicus) | 6480464 | Propylthiouracil results in increased expression of DYDC2 mRNA | CTD | PMID:24780913 | 6-propyl-2-thiouracil | decreases expression | ISO | Dydc2 (Rattus norvegicus) | 6480464 | Propylthiouracil results in decreased expression of DYDC2 mRNA | CTD | PMID:25825206 and PMID:30047161 | acrylamide | decreases expression | ISO | Dydc2 (Rattus norvegicus) | 6480464 | Acrylamide results in decreased expression of DYDC2 mRNA | CTD | PMID:28959563 | all-trans-retinoic acid | decreases expression | EXP | | 6480464 | Tretinoin results in decreased expression of DYDC2 mRNA | CTD | PMID:23724009 | amitrole | decreases expression | ISO | Dydc2 (Rattus norvegicus) | 6480464 | Amitrole results in decreased expression of DYDC2 mRNA | CTD | PMID:30047161 | atrazine | increases expression | EXP | | 6480464 | Atrazine results in increased expression of DYDC2 mRNA | CTD | PMID:22378314 | benzo[a]pyrene | affects methylation | EXP | | 6480464 | Benzo(a)pyrene affects the methylation of DYDC2 promoter | CTD | PMID:27901495 | benzo[a]pyrene | increases methylation | EXP | | 6480464 | Benzo(a)pyrene results in increased methylation of DYDC2 exon | CTD | PMID:27901495 | benzo[a]pyrene | decreases methylation | EXP | | 6480464 | Benzo(a)pyrene results in decreased methylation of DYDC2 5' UTR | CTD | PMID:27901495 | benzo[e]pyrene | increases methylation | EXP | | 6480464 | benzo(e)pyrene results in increased methylation of DYDC2 promoter | CTD | PMID:30157460 | bisphenol A | decreases expression | ISO | Dydc2 (Mus musculus) | 6480464 | bisphenol A results in decreased expression of DYDC2 mRNA | CTD | PMID:26063408 and PMID:30245210 | bisphenol A | increases methylation | ISO | Dydc2 (Rattus norvegicus) | 6480464 | bisphenol A results in increased methylation of DYDC2 gene | CTD | PMID:28505145 | bisphenol A | decreases expression | ISO | Dydc2 (Rattus norvegicus) | 6480464 | bisphenol A results in decreased expression of DYDC2 mRNA | CTD | PMID:25181051 more ... | butanal | increases expression | EXP | | 6480464 | butyraldehyde results in increased expression of DYDC2 mRNA | CTD | PMID:26079696 | carbon nanotube | decreases expression | ISO | Dydc2 (Mus musculus) | 6480464 | Nanotubes more ... | CTD | PMID:25554681 | copper(II) sulfate | increases expression | EXP | | 6480464 | Copper Sulfate results in increased expression of DYDC2 mRNA | CTD | PMID:19549813 | Cuprizon | increases expression | ISO | Dydc2 (Rattus norvegicus) | 6480464 | Cuprizone results in increased expression of DYDC2 mRNA | CTD | PMID:26577399 | cyclosporin A | increases expression | EXP | | 6480464 | Cyclosporine results in increased expression of DYDC2 mRNA | CTD | PMID:21632981 and PMID:25562108 | dicrotophos | decreases expression | EXP | | 6480464 | dicrotophos results in decreased expression of DYDC2 mRNA | CTD | PMID:28302478 | dorsomorphin | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of DYDC2 mRNA | CTD | PMID:27188386 | ethyl methanesulfonate | increases expression | EXP | | 6480464 | Ethyl Methanesulfonate results in increased expression of DYDC2 mRNA | CTD | PMID:23649840 | ethylparaben | decreases expression | EXP | | 6480464 | ethyl-p-hydroxybenzoate results in decreased expression of DYDC2 mRNA | CTD | PMID:37690743 | formaldehyde | increases expression | EXP | | 6480464 | Formaldehyde results in increased expression of DYDC2 mRNA | CTD | PMID:23649840 | genistein | decreases expression | ISO | Dydc2 (Mus musculus) | 6480464 | Genistein results in decreased expression of DYDC2 mRNA | CTD | PMID:32186404 | methamphetamine | increases expression | ISO | Dydc2 (Rattus norvegicus) | 6480464 | Methamphetamine results in increased expression of DYDC2 mRNA | CTD | PMID:28341135 | methapyrilene | increases methylation | EXP | | 6480464 | Methapyrilene results in increased methylation of DYDC2 promoter | CTD | PMID:30157460 | methimazole | decreases expression | ISO | Dydc2 (Rattus norvegicus) | 6480464 | Methimazole results in decreased expression of DYDC2 mRNA | CTD | PMID:30047161 | methyl methanesulfonate | increases expression | EXP | | 6480464 | Methyl Methanesulfonate results in increased expression of DYDC2 mRNA | CTD | PMID:23649840 | pentanal | increases expression | EXP | | 6480464 | pentanal results in increased expression of DYDC2 mRNA | CTD | PMID:26079696 | phenylmercury acetate | decreases expression | EXP | | 6480464 | Phenylmercuric Acetate results in decreased expression of DYDC2 mRNA | CTD | PMID:26272509 | phenylmercury acetate | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of DYDC2 mRNA | CTD | PMID:27188386 | pirinixic acid | multiple interactions | EXP | | 6480464 | [pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of DYDC2 mRNA | CTD | PMID:19710929 | potassium dichromate | increases expression | ISO | Dydc2 (Mus musculus) | 6480464 | Potassium Dichromate results in increased expression of DYDC2 mRNA | CTD | PMID:23608068 | pregnenolone 16alpha-carbonitrile | decreases expression | ISO | Dydc2 (Rattus norvegicus) | 6480464 | Pregnenolone Carbonitrile results in decreased expression of DYDC2 mRNA | CTD | PMID:30047161 | propanal | increases expression | EXP | | 6480464 | propionaldehyde results in increased expression of DYDC2 mRNA | CTD | PMID:26079696 | quercetin | increases expression | EXP | | 6480464 | Quercetin results in increased expression of DYDC2 mRNA | CTD | PMID:21632981 | SB 431542 | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of DYDC2 mRNA | CTD | PMID:27188386 | sodium arsenite | increases expression | EXP | | 6480464 | sodium arsenite results in increased expression of DYDC2 mRNA | CTD | PMID:29301061 | sodium fluoride | decreases expression | ISO | Dydc2 (Mus musculus) | 6480464 | Sodium Fluoride results in decreased expression of DYDC2 mRNA | CTD | PMID:27862939 | titanium dioxide | decreases expression | ISO | Dydc2 (Mus musculus) | 6480464 | titanium dioxide results in decreased expression of DYDC2 mRNA | CTD | PMID:23557971 | trichloroethene | increases expression | ISO | Dydc2 (Rattus norvegicus) | 6480464 | Trichloroethylene results in increased expression of DYDC2 mRNA | CTD | PMID:33387578 | valproic acid | increases methylation | EXP | | 6480464 | Valproic Acid results in increased methylation of DYDC2 gene | CTD | PMID:29154799 | valproic acid | increases expression | EXP | | 6480464 | Valproic Acid results in increased expression of DYDC2 mRNA | CTD | PMID:29154799 | |